Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence

Published:2018-01 Issue:7688 Volume:553 Page:351-355
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Sulli Gabriele,Rommel Amy,Wang Xiaojie,Kolar Matthew J.,Puca Francesca,Saghatelian Alan,Plikus Maksim V.,Verma Inder M.,Panda Satchidananda

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature25170.pdf

Reference39 articles.

1. Fu, L. & Lee, C. C. The circadian clock: pacemaker and tumour suppressor. Nat. Rev. Cancer 3, 350–361 (2003)

2. Scheiermann, C., Kunisaki, Y. & Frenette, P. S. Circadian control of the immune system. Nat. Rev. Immunol. 13, 190–198 (2013)

3. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011)

4. Straif, K. et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 8, 1065–1066 (2007)

5. Cho, H. et al. Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β. Nature 485, 123–127 (2012)

Cited by 274 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ticking Brain: Circadian Rhythm as a New Target for Cerebroprotection;Stroke;2024-09

2. Dual perspective on autophagy in glioma: Detangling the dichotomous mechanisms of signaling pathways for therapeutic insights;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

3. Regulation of exercise ability and glycolipid metabolism by synthetic SR9009 analogues as new REV-ERB-α agonists;Bioorganic & Medicinal Chemistry;2024-09

4. Rev-erbα deletion promotes gastric cancer progression through attenuating DLAT and DLST induced cuproptosis;2024-08-19

5. Epigenetic regulations of cellular senescence in osteoporosis;Ageing Research Reviews;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3